The ultrasonic visualization of carcinoma of the breast and other soft-tissue structures

Howry, Douglass H.; Stott, Dorothy A.; Bliss, W.

doi:10.1002/1097-0142(195403)7:2<354::aid-cncr2820070220>3.0.co;2-9

Cited by 74 publications

(19 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2) [ 53 , 54 ] . In the late 1970s, concern about the level of radiation from mammography led to an interest in utilization of ultrasonography to screen for breast cancer.…”

Section: Resultsmentioning

confidence: 99%

The emergence of diagnostic imaging technologies in breast cancer: discovery, regulatory approval, reimbursement, and adoption in clinical guidelines

et al. 2012

View full text Add to dashboard Cite

In this article, we trace the chronology of developments in breast imaging technologies that are used for diagnosis and staging of breast cancer, including mammography, ultrasonography, magnetic resonance imaging, computed tomography, and positron emission tomography. We explore factors that affected clinical acceptance and utilization of these technologies from discovery to clinical use, including milestones in peer-reviewed publication, US Food and Drug Administration approval, reimbursement by payers, and adoption into clinical guidelines. The factors driving utilization of new imaging technologies are mainly driven by regulatory approval and reimbursement by payers rather than evidence that they provide benefits to patients. Comparative effectiveness research can serve as a useful tool to investigate whether these imaging modalities provide information that improves patient outcomes in real-world settings.

show abstract